The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
The company will now explore a buyer for its manufacturing site and exit in due course
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Department presents a detailed overview of the Pharma and MediTechsector and gives a detailed presentation on the activities of Department
EDQM has also issued a Certificate of Suitability for Allopurino
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Subscribe To Our Newsletter & Stay Updated
